The supervisory board had not discussed buying back VTBshares, Ulyukayev told reporters after a board meeting. VTB shares have jumped almost 30 percent since lastThursday, mostly on news last week that the bank might buy backshares at the IPO price -- roughly four times more than they areworth now. But they fell 7.8 percent on Wednesday after AlexeiSavatyugin, a senior Finance Ministry official and a member ofthe bank's board, said the board was unlikely to support thebuyback. Consumer Product Safety CommissionCPSC Media Contact, +1-301-504-7908. * Div to be slightly above 11 pct of 2008 net income Russia * Net calculated to Russian accounting standards * 2007 div was 25 pct of net profit * Board did not discuss share buyback(Adds background) MOSCOW, May 13 (Reuters) - Russian state-run bank VTB(VTBR.MM) will pay a dividend of "a little more than 11 percent"of its 2008 net income, as calculated to Russian accountingstandards, board member Alexei Ulyukayev said on Wednesday VTB's 2007 dividend was 25 percent of net profit.

The CPSC iscommitted to protecting consumers and families from products that pose a fire,electrical, chemical, or mechanical hazard. Consumer Product Safety Commission is charged with protecting thepublic from unreasonable risks of serious injury or death from thousands oftypes of consumer products under the agency's jurisdiction. PT Monday through Friday, or visit thefirm's Web site at is still interested in receiving incident or injury reports that areeither directly related to this product recall or involve a different hazardwith the same product.Please tell us about it by clicking here.The U.S. brands) nationwide from January 2005 to August 2008for between $1.50 and $2.25 per linear foot.Manufactured in:United StatesRemedy:Consumers with the recalled decking should immediately contact LP fora free inspection.If the decking is affected by premature deterioration, LPwill arrange for a free replacement.Consumer Contact: For additional information, contact LP toll-free at (888)325-1184 between 6 a.m and 5 p.m. Sold at: The Home Depot (Veranda(R) brand) and building product dealers (LPWeatherBest(R) and ABTCo. Without product differentiation,they have been unable to capture the attention of consumers.

"Each manufacturerstrives to introduce their own device features and innovations to differentiatetheir devices; it essentially amounts to how these devices are perceived in themind of specialists," explains the analyst of this research. Product Differentiation and Innovation Critical to Competitive Success The CRM market consists of a select few market participants trying to sellhigh-cost, life-saving devices. "To position a company for future growth, building an effectivechannel to profitably distribute lower cost equipment to new, emerging users isabsolutely essential." At the same time, international manufacturers should aimto establish alliances with smaller participants for the sale and distributionof their products. Overall, the western European CRM market earnedrevenues of $3.4 billion in 2008 and is estimated to reach $7.3 billion in 2015."Collaborative partnerships, technological innovation and device scalabilitywill determine the future of the European CRM market," notes the analyst of thisresearch. Certain segments such as CRT-P andleads, while expanding gradually, are still exhibiting a positive growth rate.The CRM industry reveals natural, organic growth with all market participantsset to make revenue gains. The major segments of the CRM market are achieving rapid penetration, indicativeof a flourishing space for CRM devices.

The approval of implantable CRM therapy forcongestive heart failure by means of cardiac resynchronisation therapy devices;regulatory approval of advanced technologies such as ablation catheters and costbenefits accrued to the national healthcare system are invigorating theexpansion of the CRM market. As a result, the European cardiac rhythm management (CRM) market offerssignificant growth potential. Each year cardiovascular diseasescause over 4.3 million deaths, accounting for 48 per cent of all mortalities inEurope. Market Overview Advanced Technologies to Support Expansion of European Cardiac Rhythm ManagementThe incidence of cardiovascular disease is rising due to factors such as ageing,obesity, smoking and other cardiac ailments. In this research, Frost & Sullivan's expert analysts thoroughlyexamine the following markets: pacemakers, implantable cardioverterdefibrillators, cardiac resynchronisation devices and ablation catheters andleads.